medical oncologist and clinician scientist
Australia
Joined May 2014
- Tweets2.3K
- Following133
- Followers1.4K
- Likes1.4K
Professor DM Thomas retweeted
Wow! Marked reduction of LDL cholesterol with one shot PCSK9 gene base editing 👉🏼In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia | New England Journal of Medicine @NEJM @skathire 👏🏼👏🏼👏🏼
nejm.org/doi/full/10.1056/NE…
Professor DM Thomas retweeted
Today, on #InternationalNursesDay, we celebrate the extraordinary nurses at Peter Mac and beyond.
Our #nurses provide some of the most specialised cancer care in the world - constantly pushing the boundaries of what exceptional cancer care looks like.
Professor DM Thomas retweeted
Peter Mac is set to become the first centre to treat a patient under a new PBS-funded CAR T-cell therapy program for multiple myeloma — marking a major step forward for patients with limited options.
More: petermac.org/about-us/news-a…
Professor DM Thomas retweeted
”Failure is really important. Experiments don't have to succeed.”
Medicine laureate Richard Roberts shares some of his best advice to young students about staying creative, being true to yourself and listening to nature – which can lead to discoveries.
Roberts shared the 1993 Nobel Prize in Physiology or Medicine with Phillip Sharp for their discoveries of split genes.
Watch the full conversation: bit.ly/4izEe1q
Professor DM Thomas retweeted
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer Treatment | JCO Precision Oncology ascopubs.org/doi/10.1200/PO-…
Professor DM Thomas retweeted
There’s a Revolution in Cancer. But Can Big Pharma Afford It?
Revolution Medicines could soon launch a pancreatic-cancer drug. Its stock may already be beyond what established pharmaceutical firms can pay cc @Aiims1742 @DavidHongMD
wsj.com/finance/investing/th…
Professor DM Thomas retweeted
This is a saddening turn in the remarkable story around this manuscript.
This paper achieved unseen popular attention and its content was positioned as a new hope for patients with #PancreaticCancer - the lack of transparency is concerning.
PNAS retracted Mariano Barbacid’s Dec 2025 paper on a triple therapy (daraxonrasib + afatinib + SD-36) that achieved complete pancreatic tumor regression in 45 mice.
The sole reason: undisclosed financial stakes by Barbacid and two co-authors in Vega Oncotargets startup. Scientific findings were not challenged. The authors will resubmit with proper disclosure.
Professor DM Thomas retweeted
A man spends 50 years teaching at MIT.
He knows his time is running out.
So he records one last lecture — everything he knows, distilled into a single hour.
He died 5 months later.
This is that lecture.
The most important hour you'll watch this week. 👇
Bookmark it for later
Professor DM Thomas retweeted
This experiment breaks your brain 🤯
Remove air in the world’s largest vacuum chamber, drop a bowling ball and feathers, and Galileo is proven right—400 years later.
Professor DM Thomas retweeted
I was thrilled to hear that a recent scan showed my brain tumour area is still looking pretty good. It’s simply amazing to still be here enjoying life! I’m incredibly grateful to the outstanding medical team who care for me so well. Thank you Helen Wheeler, Michael Back, Marina Kastelan and colleagues for your dedicated teamwork. Best wishes to everyone including during our Aussie summer months!
@NthSydHealth
@Sydney_Uni
#glioblastoma
#braincancer
#Brainstorm
Professor DM Thomas retweeted
How can we measure the value of #genomics in #healthcare? How can #HTA, #implementation & data management be adapted to suit the rapidly evolving nature of genomics technologies? A new Review from Zornitza Stark, @IliasGoranitis & colleagues addresses these questions.
nature.com/articles/s41591-0…
Professor DM Thomas retweeted
🚨 End-of-year treat!
“Eleven clinical trials that will shape medicine in 2026” is now FREE to access 🧬
Discover next-gen vaccines, gene-editing tools, and long COVID therapies poised to redefine treatment.
👉 ow.ly/UOcY50XLxcg
#NatureMedicine #ClinicalTrial
Professor DM Thomas retweeted
ASCO daily news: on the importance of recognizing rare cancers, listening to patients, and performing NGS to optimize therapy
dailynews.ascopubs.org/do/st…
Professor DM Thomas retweeted
First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma | Cancer Discovery News | American Association for Cancer Research aacrjournals.org/cdnews/news…
Professor DM Thomas retweeted
ESMO Sarcoma and Rare Cancers 2026: Why register youtu.be/C9xdG-PxtJg?si=PzCj… via @YouTube
Professor DM Thomas retweeted
⭐️ Blown away by the flood of DMs, emails & texts 👉🏼from leaders across industry & academia, echoing alignment with our JCO commentary: “Precision Oncology and Modernizing Evidence Standards.” Deep thanks to @JCO_ASCO @ASCO for publishing it.🙏🏽🎉 @OncoAlert @Dr_R_Kurzrock
ascopubs.org/doi/10.1200/JCO…
Professor DM Thomas retweeted
⭐️All roads lead to ROME: convergence of evidence in precision oncology - @myESMO @ESMO_Open
esmoopen.com/article/S2059-7…
Professor DM Thomas retweeted
Hans Gelderblom, David M. Thomas, and Peter Horak discussed "Omics to Guide Precision Therapy" in a plenary session to close out the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
#Targets25 @ProfDMThomas
Professor DM Thomas retweeted
2/ When people offhandedly say that doctors are withholding the cure to cancer, it literally causes me physical pain. What I want more than anything is for science to speed up. To develop cures. To make cancer a thing of the past so the patients I cherish can live full lives.